{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T18:16:09Z","timestamp":1788891369839,"version":"build-2803163510"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T00:00:00Z","timestamp":1560988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To determine whether taking hydroxychloroquine (HCQ) could prevent the development of new-onset diabetes mellitus (DM) among patients with Sj\u00f6gren syndrome (SS).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This is a nationwide, population-based, retrospective cohort study utilizing the Taiwan National Health Insurance Research Database (NHIRD). Data were collected from 1 January 1999, through 31 December 2013, using the International Classification of Diseases, Ninth Revision, Clinical Modification codes. In total, 7774 patients newly diagnosed with SS by at least three outpatient visits or one inpatient admission were selected from the NHIRD as participants. Patients who had previously been diagnosed with DM and whose follow-up durations shorter than 90 days were excluded. HCQ exposure group includes patients who had been diagnosed with SS no longer than 180 days previously, and had been prescribed HCQ for the first time for at least 90 days. The diagnosis of DM was defined as at least two outpatient visits or one inpatient admission with anti-diabetic medication prescription.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Patients with SS treated with HCQ had a significantly lower cumulative incidence of new-onset DM than those not treated with HCQ (adjusted hazard ratio: 0.51, 95% confidence interval: 0.28\u20130.96, P &lt; 0.05). HCQ use for 3 years or more had favorable protective effects (adjusted hazard ratio: 0.22, CI: 0.05\u20130.92).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>HCQ reduced the incidence of DM in a time and dose-dependent manner. Patients with SS who had taken HCQ for 3 years or more exhibited significant protective effects against developing new-onset DM.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/qjmed\/hcz112","type":"journal-article","created":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T08:18:46Z","timestamp":1560500326000},"page":"757-762","source":"Crossref","is-referenced-by-count":19,"title":["Hydroxychloroquine was associated with reduced risk of new-onset diabetes mellitus in patients with Sj\u00f6gren syndrome"],"prefix":"10.1093","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9873-5851","authenticated-orcid":false,"given":"T -H","family":"Chen","sequence":"first","affiliation":[{"name":"School of Medicine, Chung Shan Medical University, Taichung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T -Y","family":"Lai","sequence":"additional","affiliation":[{"name":"School of Medicine, Chung Shan Medical University, Taichung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y -H","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Medical Research, Chung Shan Medical University, Taichung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J -Y","family":"Chiou","sequence":"additional","affiliation":[{"name":"School of Health Policy and Management, Chung Shan Medical University, Taichung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y -M","family":"Hung","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan"},{"name":"School of Medicine, National Yang Ming University, Taipei, Taiwan"},{"name":"Yuhing Junior College of Health Care and Management, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J C -C","family":"Wei","sequence":"additional","affiliation":[{"name":"Division of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital and Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan"},{"name":"Graduate Institute of Integrated Medicine, China Medical University, Taichung City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,6,20]]},"reference":[{"key":"2019100900585189000_hcz112-B1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","article-title":"Sj\u00f6gren\u2019s syndrome","volume":"366","author":"Fox","year":"2005","journal-title":"Lancet"},{"key":"2019100900585189000_hcz112-B2","first-page":"659","article-title":"Prevalence of primary Sj\u00f6gren\u2019s syndrome in China","volume":"22","author":"Zhang","year":"1995","journal-title":"J Rheumatol"},{"key":"2019100900585189000_hcz112-B3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1600-0420.1997.tb00774.x","article-title":"Keratoconjunctivitis sicca and primary Sj\u00f6gren\u2019s syndrome in a Danish population aged 30-60 years","volume":"75","author":"Bjerrum","year":"1997","journal-title":"Acta Ophthalmol Scand"},{"key":"2019100900585189000_hcz112-B4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/rheumatology\/38.2.164","article-title":"Prevalence of Sj\u00f6gren\u2019s syndrome in Slovenia","volume":"38","author":"Tomsic","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"2019100900585189000_hcz112-B5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/rheumatology\/kei107","article-title":"Epidemiology of primary Sj\u00f6gren\u2019s syndrome in north-west Greece, 1982-2003","volume":"45","author":"Alamanos","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"2019100900585189000_hcz112-B6","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/03009740600759704","article-title":"The prevalence of Sj\u00f6gren\u2019s syndrome in adult women","volume":"35","author":"Kabasakal","year":"2006","journal-title":"Scand J Rheumatol"},{"key":"2019100900585189000_hcz112-B7","doi-asserted-by":"crossref","first-page":"13871.","DOI":"10.1038\/srep13871","article-title":"Subsequent Type 2 diabetes in patients with autoimmune disease","volume":"5","author":"Hemminki","year":"2015","journal-title":"Sci Rep"},{"key":"2019100900585189000_hcz112-B8","first-page":"1896","article-title":"Alleles from chromosomes 1 and 3 of NOD mice combine to influence Sj\u00f6gren\u2019s syndrome-like autoimmune exocrinopathy","volume":"27","author":"Brayer","year":"2000","journal-title":"J Rheumatol"},{"key":"2019100900585189000_hcz112-B9","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/rheumatology\/28.6.518","article-title":"Sj\u00f6gren\u2019s syndrome: association with type-1 diabetes mellitus","volume":"28","author":"Binder","year":"1989","journal-title":"Br J Rheumatol"},{"key":"2019100900585189000_hcz112-B10","doi-asserted-by":"crossref","first-page":"900","DOI":"10.2337\/diacare.15.7.900","article-title":"Xerostomia in diabetes mellitus","volume":"15","author":"Sreebny","year":"1992","journal-title":"Diabetes Care"},{"key":"2019100900585189000_hcz112-B11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10787-015-0239-y","article-title":"Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases","volume":"23","author":"Rainsford","year":"2015","journal-title":"Inflammopharmacology"},{"key":"2019100900585189000_hcz112-B12","first-page":"678","article-title":"Hydroxychloroquine in decompensated, treatment-refractory noninsulin-dependent diabetes mellitus","volume":"112","author":"Quatraro","year":"1990","journal-title":"A new job for an old drug? Ann Intern Med"},{"key":"2019100900585189000_hcz112-B13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1377\/hlthaff.22.3.61","article-title":"Taiwan\u2019s new national health insurance program: genesis and experience so far","volume":"22","author":"Cheng","year":"2003","journal-title":"Health Aff (Millwood)"},{"key":"2019100900585189000_hcz112-B14","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"2019100900585189000_hcz112-B15","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/rheumatology\/keu451","article-title":"Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study","volume":"54","author":"Chen","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"2019100900585189000_hcz112-B16","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2147\/TCRM.S130666","article-title":"Association between use of disease-modifying antirheumatic drugs and diabetes in patients with ankylosing spondylitis, rheumatoid arthritis, or psoriasis\/psoriatic arthritis: a nationwide, population-based cohort study of 84, 989 patients","volume":"13","author":"Chen","year":"2017","journal-title":"Ther Clin Risk Manag"},{"key":"2019100900585189000_hcz112-B17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jama.298.2.187","article-title":"Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis","volume":"298","author":"Wasko","year":"2007","journal-title":"JAMA"},{"key":"2019100900585189000_hcz112-B18","doi-asserted-by":"crossref","first-page":"R135.","DOI":"10.1186\/ar3868","article-title":"Hydroxychloroquine improves insulin sensitivity in obese non-diabetic individuals","volume":"14","author":"Mercer","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"2019100900585189000_hcz112-B19","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2174\/1389450033490920","article-title":"Insulin resistance as a proinflammatory state: mechanisms, mediators, and therapeutic interventions","volume":"4","author":"Garg","year":"2003","journal-title":"Curr Drug Targets"},{"key":"2019100900585189000_hcz112-B20","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI25102","article-title":"Inflammation, stress, and diabetes","volume":"115","author":"Wellen","year":"2005","journal-title":"J Clin Invest"},{"key":"2019100900585189000_hcz112-B21","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.immuni.2011.01.021","article-title":"A subset of interleukin-21+ chemokine receptor CCR9+ T helper cells target accessory organs of the digestive system in autoimmunity","volume":"34","author":"McGuire","year":"2011","journal-title":"Immunity"},{"key":"2019100900585189000_hcz112-B22","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10067-015-3072-1","article-title":"Metabolic syndrome in Sj\u00f6gren\u2018s syndrome patients: a relevant concern for clinical monitoring","volume":"35","author":"Augusto","year":"2016","journal-title":"Clin Rheumatol"},{"key":"2019100900585189000_hcz112-B23","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0049-0172(10)80012-5","article-title":"Mechanism of action of hydroxychloroquine as an antirheumatic drug","volume":"23","author":"Fox","year":"1993","journal-title":"Semin Arthritis Rheum"}],"container-title":["QJM: An International Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/qjmed\/advance-article-pdf\/doi\/10.1093\/qjmed\/hcz150\/28924886\/hcz150.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/qjmed\/article-pdf\/112\/10\/757\/30121416\/hcz112.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/qjmed\/article-pdf\/112\/10\/757\/30121416\/hcz112.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T00:59:16Z","timestamp":1570582756000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/qjmed\/article\/112\/10\/757\/5520956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,20]]},"references-count":23,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,6,20]]},"published-print":{"date-parts":[[2019,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/qjmed\/hcz112","relation":{},"ISSN":["1460-2725","1460-2393"],"issn-type":[{"value":"1460-2725","type":"print"},{"value":"1460-2393","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,10]]},"published":{"date-parts":[[2019,6,20]]}}}